Wong, Samantha A. http://orcid.org/0000-0001-7554-3737
Lebois, Lauren A. M. http://orcid.org/0000-0001-5816-9181
Ely, Timothy D. http://orcid.org/0000-0002-5690-5234
van Rooij, Sanne J. H. http://orcid.org/0000-0002-0160-7248
Bruce, Steven E. http://orcid.org/0000-0002-5807-4382
Murty, Vishnu P.
Jovanovic, Tanja
House, Stacey L.
Beaudoin, Francesca L.
An, Xinming
Zeng, Donglin
Neylan, Thomas C. http://orcid.org/0000-0002-1572-2626
Clifford, Gari D.
Linnstaedt, Sarah D. http://orcid.org/0000-0001-5295-7072
Germine, Laura T. http://orcid.org/0000-0001-8690-8412
Bollen, Kenneth A.
Rauch, Scott L.
Haran, John P. http://orcid.org/0000-0001-7311-1121
Storrow, Alan B. http://orcid.org/0000-0002-2893-808X
Lewandowski, Christopher http://orcid.org/0000-0001-8297-0024
Musey, Paul I. Jr. http://orcid.org/0000-0002-5693-190X
Hendry, Phyllis L.
Sheikh, Sophia http://orcid.org/0000-0003-1939-3126
Jones, Christopher W.
Punches, Brittany E. http://orcid.org/0000-0002-7546-1966
Kurz, Michael C.
Swor, Robert A.
Hudak, Lauren A.
Pascual, Jose L.
Seamon, Mark J.
Pearson, Claire
Peak, David A.
Merchant, Roland C.
Domeier, Robert M.
Rathlev, Niels K.
O’Neil, Brian J.
Sergot, Paulina
Sanchez, Leon D.
Miller, Mark W. http://orcid.org/0000-0001-6393-8563
Pietrzak, Robert H.
Joormann, Jutta
Barch, Deanna M. http://orcid.org/0000-0003-1693-8506
Pizzagalli, Diego A. http://orcid.org/0000-0002-7772-1143
Harte, Steven E.
Elliott, James M.
Kessler, Ronald C. http://orcid.org/0000-0003-4831-2305
Koenen, Karestan C. http://orcid.org/0000-0003-2978-7655
McLean, Samuel A. http://orcid.org/0000-0001-9482-3582
Ressler, Kerry J. http://orcid.org/0000-0002-5158-1103
Stevens, Jennifer S. http://orcid.org/0000-0003-4674-0314
Harnett, Nathaniel G. http://orcid.org/0000-0001-5346-2012
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K00MH119603, U01MH110925)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 14 October 2022
Revised: 17 February 2023
Accepted: 22 February 2023
First Online: 17 March 2023
Competing interests
: LAML reports unpaid membership on the Scientific Committee for the International Society for the Study of Trauma and Dissociation (ISSTD), grant support from the National Institute of Mental Health (NIMH), K01 MH118467, and the Julia Kasparian Fund for Neuroscience Research. LAML also reports spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work. TCN has received research support from NIH, VA, and Rainwater Charitable Foundation, and consulting income from Jazz Pharmaceuticals. In the last 3 years GDC has received research funding from the NSF, NIH and LifeBell AI, and unrestricted donations from AliveCor Inc, Amazon Research, the Center for Discovery, the Gates Foundation, Google, the Gordon and Betty Moore Foundation, MathWorks, Microsoft Research, Nextsense Inc, One Mind Foundation, the Rett Research Foundation, and Samsung Research. GDC has financial interest in AliveCor Inc and Nextsense Inc. He also is the CTO of MindChild Medical and CSO of LifeBell AI and has ownership in both companies. These relationships are unconnected to the current work. SLR reports grants from NIH during the conduct of the study; personal fees from SOBP (Society of Biological Psychiatry) paid role as secretary, other from Oxford University Press royalties, other from APP (American Psychiatric Publishing Inc.) royalties, other from VA (Veterans Administration) per diem for oversight committee, and other from Community Psychiatry/Mindpath Health paid board service, including equity outside the submitted work; other from National Association of Behavioral Healthcare for paid Board service; and Leadership roles on Board or Council for SOBP, ADAA (Anxiety and Depression Association of America), and NNDC (National Network of Depression Centers). SS has received funding from the Florida Medical Malpractice Joint Underwriter’s Association Dr. Alvin E. Smith Safety of Healthcare Services Grant; Allergan Foundation; the NIH/NIA-funded Jacksonville Aging Studies Center (JAX-ASCENT; R33AG05654); and the Substance Abuse and Mental Health Services Administration (1H79TI083101-01); and the Florida Blue Foundation. CWJ has no competing interests related to this work, though he has been an investigator on studies funded by AstraZeneca, Vapotherm, Abbott, and Ophirex. JJ receives consulting payments from Janssen Pharmaceuticals. DMB has received function from the NIMH, NIDA, and the American Foundation for Suicide Prevention, and consults for Boehringer Ingelheim. Over the past 3 years, DAP has received consulting fees from Albright Stonebridge Group, Boehringer Ingelheim, Compass Pathways, Concert Pharmaceuticals, Engrail Therapeutics, Neumora Therapeutics (former BlackThorn Therapeutics), Neurocrine Biosciences, Neuroscience Software, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals; honoraria from the Psychonomic Society (for editorial work) and Alkermes, and research funding from NIMH, Dana Foundation, Brain and Behavior Research Foundation, and Millennium Pharmaceuticals. In addition, he has received stock options from Neumora Therapeutics (former BlackThorn Therapeutics), Compass Pathways, Engrail Therapeutics, and Neuroscience Software. SEH has no competing interests related to this work, though in the last three years he has received research funding from NIH, Aptinyx, and Arbor Medical Innovations, and consulting payments from Aptinyx, Heron Therapeutics, and Memorial Sloan Kettering Cancer Center. JME reports support from the National Institutes of Health (NIH) through Grant Numbers R01HD079076 & R03HD094577: Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Center for Medical Rehabilitation Research. He also reports funding from New South Wales Health, Spinal Cord Injury Award (2020–2025) and consulting fees (<$15,000 per annum) from Orofacial Therapeutics, LLC. In the past 3 years, RCK was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Holmusk, Partners Healthcare, Inc., RallyPoint Networks, Inc., and Sage Therapeutics. He has stock options in Cerebral Inc., Mirah, PYM, and Roga Sciences. KCK research has been supported by the Robert Wood Johnson Foundation, the Kaiser Family Foundation, the Harvard Center on the Developing Child, Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, the National Institutes of Health, One Mind, the Anonymous Foundation, and Cohen Veterans Bioscience. She has been a paid consultant for Baker Hostetler, Discovery Vitality, and the Department of Justice. She has been a paid external reviewer for the Chan Zuckerberg Foundation, the University of Cape Town, and Capita Ireland. She has had paid speaking engagements in the last 3 years with the American Psychological Association, European Central Bank. Sigmund Freud University – Milan, Cambridge Health Alliance, and Coverys. She receives royalties from Guilford Press and Oxford University Press. SAM serves as a consultant for Walter Reed and for Arbor Medical Innovations. KJR has performed scientific consultation for Bioxcel, Bionomics, Acer, Takeda, and Jazz Pharma; serves on Scientific Advisory Boards for Sage and the Brain Research Foundation, and he has received sponsored research support from Takeda, Brainsway and Alto Neuroscience. NGH reports grant support from the National Institute of Mental Health, K00 MH119603.